Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

Detalles Bibliográficos
Autores principales: Link-Gelles, Ruth, Weber, Zachary A., Reese, Sarah E., Payne, Amanda B., Gaglani, Manjusha, Adams, Katherine, Kharbanda, Anupam B., Natarajan, Karthik, DeSilva, Malini B., Dascomb, Kristin, Irving, Stephanie A., Klein, Nicola P., Grannis, Shaun J., Ong, Toan C., Embi, Peter J., Dunne, Margaret M., Dickerson, Monica, McEvoy, Charlene, Arndorfer, Julie, Naleway, Allison L., Goddard, Kristin, Dixon, Brian E., Griggs, Eric P., Hansen, John, Valvi, Nimish, Najdowski, Morgan, Timbol, Julius, Rogerson, Colin, Fireman, Bruce, Fadel, William F., Patel, Palak, Ray, Caitlin S., Wiegand, Ryan, Ball, Sarah, Tenforde, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231940/
https://www.ncbi.nlm.nih.gov/pubmed/37227984
http://dx.doi.org/10.15585/mmwr.mm7221a3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231940/
https://www.ncbi.nlm.nih.gov/pubmed/37227984
http://dx.doi.org/10.15585/mmwr.mm7221a3

Ejemplares similares